This inventor holds 4 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignees: Glytech, Inc., Otsuka Chemical Co., Ltd.. Active years: 2012-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2014
Title: Mugio Nishizawa: Innovator in Pharmaceutical Compounds
Introduction
Mugio Nishizawa is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative compounds. With a total of 4 patents, his work focuses on enhancing immunopotentiating activities and neurotrophic factor activities.
Latest Patents
Nishizawa's latest patents include a trehalose compound and a bis(tetrahydrofuran) compound. The trehalose compound is characterized by its high immunopotentiating activity and low toxicity. It is represented by a specific formula where various groups are defined, showcasing its potential in activating macrophages and neutrophils. The bis(tetrahydrofuran) compound, on the other hand, is noted for its excellent neurotrophic factor activity-enhancing effect. This compound also has a defined formula, indicating its structural complexity and potential applications in neurobiology.
Career Highlights
Throughout his career, Nishizawa has worked with prominent companies such as Glytech, Inc. and Otsuka Chemical Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical products.
Collaborations
Nishizawa has collaborated with notable coworkers, including Hiroshi Imagawa and Masataka Oda. These partnerships have likely facilitated the advancement of his research and the successful development of his patented compounds.
Conclusion
Mugio Nishizawa's contributions to pharmaceutical innovations highlight his role as a significant inventor in the field. His patents reflect a commitment to enhancing health through innovative compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
